HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The beneficial effect of plasmapheresis in mixed connective tissue disease with coexisting antiphospholipid syndrome.

Abstract
The authors report a rare case of a female patient with mixed connective tissue disease (MCTD) with coexisting antiphospholipid syndrome (APS). Five years after the diagnosis of MCTD high concentrations of anticardiolipin (anti-CL) and anti-β2-glycoprotein (anti-β2GPI) autoantibodies were present in the patient's serum without thrombotic events. Epstein-Barr virus (EBV) reactivation provoked APS, with the clinical manifestations of livedo reticularis, digital gangrene and leg ulcers. Skin biopsy from the necrotic area showed multiple fibrin microthrombi in the superficial vessels. Corticosteroid pulse therapy, and plasma exchange in combination with synchronized cyclophosphamide was administered, which led to improvement of the digital gangrenes, while no new lesions developed. The number of CD27high plasma cells decreased, and the previous high levels of autoantibodies also normalized in the peripheral blood. In the case of MCTD with coexisting APS combination therapy, including plasmapheresis has beneficial effects.
AuthorsP Szodoray, A Hajas, L Toth, S Szakall, B Nakken, P Soltesz, E Bodolay
JournalLupus (Lupus) Vol. 23 Issue 10 Pg. 1079-84 (Sep 2014) ISSN: 1477-0962 [Electronic] England
PMID24795068 (Publication Type: Case Reports, Journal Article)
Copyright© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.
Chemical References
  • Adrenal Cortex Hormones
  • Antibodies, Antiphospholipid
  • Biomarkers
  • Immunosuppressive Agents
Topics
  • Adrenal Cortex Hormones (administration & dosage)
  • Antibodies, Antiphospholipid (blood)
  • Antiphospholipid Syndrome (blood, complications, diagnosis, immunology, therapy)
  • Biomarkers (blood)
  • Biopsy
  • Female
  • Humans
  • Immunohistochemistry
  • Immunosuppressive Agents (administration & dosage)
  • Middle Aged
  • Mixed Connective Tissue Disease (blood, complications, diagnosis, immunology, therapy)
  • Plasmapheresis
  • Pulse Therapy, Drug
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: